BioNTech Cell & Gene Therapies GmbH clinical trials

A subsidiary of BioNTech SE

The registry lists 1 studies whose lead sponsor is BioNTech Cell & Gene Therapies GmbH. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 18, 2026.

Status

Active, not recruiting: 1

Phase

Phase 1: 1

Where

Netherlands: 1
Australia: 1
Germany: 1
Sweden: 1

Registry sponsor names on this page

BioNTech Cell & Gene Therapies GmbH1 study

Something wrong with this grouping? Tell us on the BioNTech SE page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All BioNTech SE studies →

A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ TumorsActive, not recruitingNCT04503278Phase 1
Sponsor listed in the registry: BioNTech Cell & Gene Therapies GmbH